E-LIB Suche - Ergebnisse für: DeAngelo, D. J.

1

RWD114 Economic Burden, Treatment Utilization, and Medicati..:

Stanicic, F ; Zah, V ; Grbic, D..
Value in Health. 27 (2024) 6 - p. S379-S380 , 2024

Link: https://doi.org/10.1016/..

2

P356: SUBGROUP ANALYSES OF KTE-X19, AN ANTI-CD19 CHIMERIC A..:

Shah, B. D. ; Cassaday, R. D. ; Park, J. H....
HemaSphere. 6 (2022) - p. 256-257 , 2022

Link: https://doi.org/10.1097/..

3

P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS W..:

Apperley, J. ; Kantarjian, H. ; Deininger, M....
HemaSphere. 6 (2022) - p. 602-603 , 2022

Link: https://doi.org/10.1097/..

4

S129: TAKEAIM LEUKEMIA- A PHASE 1/2A STUDY OF THE IRAK4 INH..:

Garcia-Manero, G. ; Winer, E. S. ; DeAngelo, D. J....
HemaSphere. 6 (2022) - p. 30-31 , 2022

Link: https://doi.org/10.1097/..

5

Canine discrimination of ovarian cancer through volatile or..:

Kane, S.A. ; Lee, Y.E. ; Essler, J.L....
Talanta. 250 (2022) - p. 123729 , 2022

Link: https://doi.org/10.1016/..

6

P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DR..:

Daver, N. G. ; Montesinos, P. ; Aribi, A....
HemaSphere. 6 (2022) - p. 454-455 , 2022

Link: https://doi.org/10.1097/..

7

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTO..:

Reiter, A. ; Gotlib, J. ; Álvarez-Twose, I....
HemaSphere. 6 (2022) - p. 903-904 , 2022

Link: https://doi.org/10.1097/..

8

P1049: A PHASE 2 STUDY OF BEZUCLASTINIB (CGT9486), A NOVEL,..:

DeAngelo, D. J. ; Pullarkat, V. ; Piris-Villaespesa, M....
HemaSphere. 6 (2022) - p. 939-940 , 2022

Link: https://doi.org/10.1097/..

9

PB1849: TRIAL IN PROGRESS: PHASE IB/II STUDY OF SIREMADLIN ..:

Daver, N. G. ; Wei, A. H. ; Stein, E. M....
HemaSphere. 6 (2022) - p. 1729-1730 , 2022

Link: https://doi.org/10.1097/..

10

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC ..:

Reiter, A. ; Gotlib, J. ; Álvarez-Twose, I....
HemaSphere. 6 (2022) - p. 904-905 , 2022

Link: https://doi.org/10.1097/..

11

P1027: RESPONSES TO AVAPRITINIB IN PATIENTS WITH ADVANCED S..:

George, T. ; Karner, K. H. ; Moser, K. A....
HemaSphere. 6 (2022) - p. 917-918 , 2022

Link: https://doi.org/10.1097/..

12

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMG..:

Pemmaraju, N. ; Martinelli, G. ; Todisco, E....
HemaSphere. 6 (2022) - p. 1708-1709 , 2022

Link: https://doi.org/10.1097/..

13

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTAS..:

Reiter, A. ; Gotlib, J. ; Álvarez-Twose, I....
HemaSphere. 6 (2022) - p. 905-906 , 2022

Link: https://doi.org/10.1097/..

14

PRO143 PSYCHOMETRIC EVALUATION OF THE ADVANCED SYSTEMIC MAS..:

Taylor, F. ; Shields, A. ; Li, S....
Value in Health. 22 (2019) - p. S868 , 2019

Link: https://doi.org/10.1016/..

15

Expanded safety analysis of pevonedistat, a first-in-class ..:

Swords, R T ; Watts, J ; Erba, H P...
Blood Cancer Journal. 7 (2017) 2 - p. e520-e520 , 2017

Link: https://doi.org/10.1038/..